Cargando…

Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients

BACKGROUND: Cisplatin-based chemotherapy may induce nephrotoxicity. This study presents a random forest predictive model that identifies testicular cancer patients at risk of nephrotoxicity before treatment. METHODS: Clinical data and DNA from saliva samples were collected for 433 patients. These we...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Sara L, Lauritsen, Jakob, Zhang, Zeyu, Bandak, Mikkel, Dalgaard, Marlene D, Nielsen, Rikke L, Daugaard, Gedske, Gupta, Ramneek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315098/
https://www.ncbi.nlm.nih.gov/pubmed/32617516
http://dx.doi.org/10.1093/jncics/pkaa032
_version_ 1783550191390949376
author Garcia, Sara L
Lauritsen, Jakob
Zhang, Zeyu
Bandak, Mikkel
Dalgaard, Marlene D
Nielsen, Rikke L
Daugaard, Gedske
Gupta, Ramneek
author_facet Garcia, Sara L
Lauritsen, Jakob
Zhang, Zeyu
Bandak, Mikkel
Dalgaard, Marlene D
Nielsen, Rikke L
Daugaard, Gedske
Gupta, Ramneek
author_sort Garcia, Sara L
collection PubMed
description BACKGROUND: Cisplatin-based chemotherapy may induce nephrotoxicity. This study presents a random forest predictive model that identifies testicular cancer patients at risk of nephrotoxicity before treatment. METHODS: Clinical data and DNA from saliva samples were collected for 433 patients. These were genotyped on Illumina HumanOmniExpressExome-8 v1.2 (964 193 markers). Clinical and genomics-based random forest models generated a risk score for each individual to develop nephrotoxicity defined as a 20% drop in isotopic glomerular filtration rate during chemotherapy. The area under the receiver operating characteristic curve was the primary measure to evaluate models. Sensitivity, specificity, and positive and negative predictive values were used to discuss model clinical utility. RESULTS: Of 433 patients assessed in this study, 26.8% developed nephrotoxicity after bleomycin-etoposide-cisplatin treatment. Genomic markers found to be associated with nephrotoxicity were located at NAT1, NAT2, and the intergenic region of CNTN6 and CNTN4. These, in addition to previously associated markers located at ERCC1, ERCC2, and SLC22A2, were found to improve predictions in a clinical feature–trained random forest model. Using only clinical data for training the model, an area under the receiver operating characteristic curve of 0.635 (95% confidence interval [CI] = 0.629 to 0.640) was obtained. Retraining the classifier by adding genomics markers increased performance to 0.731 (95% CI = 0.726 to 0.736) and 0.692 (95% CI = 0.688 to 0.696) on the holdout set. CONCLUSIONS: A clinical and genomics-based machine learning algorithm improved the ability to identify patients at risk of nephrotoxicity compared with using clinical variables alone. Novel genetics associations with cisplatin-induced nephrotoxicity were found for NAT1, NAT2, CNTN6, and CNTN4 that require replication in larger studies before application to clinical practice.
format Online
Article
Text
id pubmed-7315098
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-73150982020-07-01 Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients Garcia, Sara L Lauritsen, Jakob Zhang, Zeyu Bandak, Mikkel Dalgaard, Marlene D Nielsen, Rikke L Daugaard, Gedske Gupta, Ramneek JNCI Cancer Spectr Article BACKGROUND: Cisplatin-based chemotherapy may induce nephrotoxicity. This study presents a random forest predictive model that identifies testicular cancer patients at risk of nephrotoxicity before treatment. METHODS: Clinical data and DNA from saliva samples were collected for 433 patients. These were genotyped on Illumina HumanOmniExpressExome-8 v1.2 (964 193 markers). Clinical and genomics-based random forest models generated a risk score for each individual to develop nephrotoxicity defined as a 20% drop in isotopic glomerular filtration rate during chemotherapy. The area under the receiver operating characteristic curve was the primary measure to evaluate models. Sensitivity, specificity, and positive and negative predictive values were used to discuss model clinical utility. RESULTS: Of 433 patients assessed in this study, 26.8% developed nephrotoxicity after bleomycin-etoposide-cisplatin treatment. Genomic markers found to be associated with nephrotoxicity were located at NAT1, NAT2, and the intergenic region of CNTN6 and CNTN4. These, in addition to previously associated markers located at ERCC1, ERCC2, and SLC22A2, were found to improve predictions in a clinical feature–trained random forest model. Using only clinical data for training the model, an area under the receiver operating characteristic curve of 0.635 (95% confidence interval [CI] = 0.629 to 0.640) was obtained. Retraining the classifier by adding genomics markers increased performance to 0.731 (95% CI = 0.726 to 0.736) and 0.692 (95% CI = 0.688 to 0.696) on the holdout set. CONCLUSIONS: A clinical and genomics-based machine learning algorithm improved the ability to identify patients at risk of nephrotoxicity compared with using clinical variables alone. Novel genetics associations with cisplatin-induced nephrotoxicity were found for NAT1, NAT2, CNTN6, and CNTN4 that require replication in larger studies before application to clinical practice. Oxford University Press 2020-04-23 /pmc/articles/PMC7315098/ /pubmed/32617516 http://dx.doi.org/10.1093/jncics/pkaa032 Text en © The Author(s) 2020. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Garcia, Sara L
Lauritsen, Jakob
Zhang, Zeyu
Bandak, Mikkel
Dalgaard, Marlene D
Nielsen, Rikke L
Daugaard, Gedske
Gupta, Ramneek
Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
title Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
title_full Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
title_fullStr Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
title_full_unstemmed Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
title_short Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
title_sort prediction of nephrotoxicity associated with cisplatin-based chemotherapy in testicular cancer patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315098/
https://www.ncbi.nlm.nih.gov/pubmed/32617516
http://dx.doi.org/10.1093/jncics/pkaa032
work_keys_str_mv AT garciasaral predictionofnephrotoxicityassociatedwithcisplatinbasedchemotherapyintesticularcancerpatients
AT lauritsenjakob predictionofnephrotoxicityassociatedwithcisplatinbasedchemotherapyintesticularcancerpatients
AT zhangzeyu predictionofnephrotoxicityassociatedwithcisplatinbasedchemotherapyintesticularcancerpatients
AT bandakmikkel predictionofnephrotoxicityassociatedwithcisplatinbasedchemotherapyintesticularcancerpatients
AT dalgaardmarlened predictionofnephrotoxicityassociatedwithcisplatinbasedchemotherapyintesticularcancerpatients
AT nielsenrikkel predictionofnephrotoxicityassociatedwithcisplatinbasedchemotherapyintesticularcancerpatients
AT daugaardgedske predictionofnephrotoxicityassociatedwithcisplatinbasedchemotherapyintesticularcancerpatients
AT guptaramneek predictionofnephrotoxicityassociatedwithcisplatinbasedchemotherapyintesticularcancerpatients